Clinical Trials Logo

Filter by:
NCT ID: NCT01089335 Completed - Thyroid Cancer Clinical Trials

Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia

SNTC
Start date: March 2010
Phase:
Study type: Observational

The standard surgical treatment for highly differentiated papillary thyroid cancer > 10 mm according to recent national and international guidelines, is total thyroidectomy and central lymphnode clearance, and for patients with cytology indicating thyroid neoplasia of unclear malignant potential hemithyroidectomy on the side of the tumour. The study investigates if the sentinel lymphnode (SN) - Reliably (with high sensitivity and specificity), can predict the pathological findings of the lymphnodes in the central compartment in patients with highly differentiated papillary thyroid cancer - Is useful to aid in the final diagnosis and staging of thyroid neoplasias of unclear malignant potential, and could be used to select patients for further central lymphnode revision.

NCT ID: NCT01088672 Completed - Ischemic Stroke Clinical Trials

Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO)

TREVO
Start date: February 2010
Phase: Phase 4
Study type: Interventional

To determine the revascularization rate of the CE-marked Trevo device in large vessel occlusions in ischemic stroke patients. - Revascularization, defined as at least TICI 2a in the vascular territory treated at end of the neuro interventional procedure.

NCT ID: NCT01087502 Completed - Clinical trials for Diabetes Mellitus, Type 2

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given over 12 weeks in drug naive or previously treated type 2 diabetic patients with moderate to severe renal impairment and insufficient glycaemic control. In addition safety in this patient population with longer term (40 week) treatment in comparison to sulfonylurea drug (glimepiride).

NCT ID: NCT01087021 Completed - Clinical trials for Neoplasms, Malignant

Effect of Cabazitaxel on the QTc Interval in Cancer Patients

QT-Cab
Start date: March 2010
Phase: Phase 1
Study type: Interventional

Primary Objective: - To assess the potential effect on QTcF interval (QTc Fridericia) of cabazitaxel in cancer patients Secondary Objectives: - To assess the effects of cabazitaxel on heart rate (HR), QT, QTcB (Bazett's correction), and QTcN (population specific correction) intervals - To assess the clinical safety of cabazitaxel - To assess cabazitaxel plasma concentrations at Cycle 1 at early timepoints (during infusion and up to 5h post end of infusion)

NCT ID: NCT01086189 Completed - Obesity Clinical Trials

Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects

Start date: December 2009
Phase: N/A
Study type: Observational

Green tea consumption could lower the risk of type II diabetes, as suggested by epidemiological studies. There is also evidence from intervention studies that green tea can decrease blood glucose levels and contribute to weight loss. The aim with this study is therefore to examine the postprandial effects of green tea on glycemic index, insulin levels and satiety in healthy individuals after the consumption of a meal.

NCT ID: NCT01085890 Completed - Blood Pressure Clinical Trials

Hypertension in Primary Health Care: Lifestyle Change and Blood Pressure Goals

Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a program that includes 1) group seminars and 2) follow-up visits with blood pressure measurement and motivational interviewing (MI) that is focused on lifestyle change affect blood pressure.

NCT ID: NCT01085123 Completed - Migraine Clinical Trials

Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers

Start date: May 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the central 5-HT1B receptor occupancy of ZOMIG® Rapimelt (zolmitriptan) in healthy male volunteers.

NCT ID: NCT01084707 Completed - Tobacco Dependence Clinical Trials

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.

Start date: January 2009
Phase: N/A
Study type: Interventional

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after multiple-doses of nicotine.

NCT ID: NCT01084603 Completed - Tobacco Dependence Clinical Trials

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

Start date: March 2009
Phase: N/A
Study type: Interventional

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after single-dose of nicotine.

NCT ID: NCT01084005 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatment in elderly patients with T2DM with insufficient glycaemic control